Published in Kidney Int on September 01, 1998
Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest (2004) 4.65
Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol (2008) 4.20
Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest (2001) 3.40
Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. J Am Soc Nephrol (2008) 2.74
Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol Cell Biol (2003) 2.69
Very low birth weight is a risk factor for secondary focal segmental glomerulosclerosis. Clin J Am Soc Nephrol (2008) 2.57
Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol (2003) 2.55
Cell biology and pathology of podocytes. Annu Rev Physiol (2011) 2.42
Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease. Kidney Int (2011) 2.28
Proteinuria: an enzymatic disease of the podocyte? Kidney Int (2009) 2.17
Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells. J Am Soc Nephrol (2009) 1.85
Glomerular Aging and Focal Global Glomerulosclerosis: A Podometric Perspective. J Am Soc Nephrol (2015) 1.76
Blood pressure influences end-stage renal disease of Cd151 knockout mice. J Clin Invest (2011) 1.75
Development of focal segmental glomerulosclerosis after anabolic steroid abuse. J Am Soc Nephrol (2009) 1.70
Urine podocyte mRNAs mark progression of renal disease. J Am Soc Nephrol (2009) 1.65
Mechanistic connection between inflammation and fibrosis. Kidney Int Suppl (2010) 1.64
Histopathology of diabetic nephropathy. Semin Nephrol (2007) 1.60
Growth-dependent podocyte failure causes glomerulosclerosis. J Am Soc Nephrol (2012) 1.60
Renal progenitor cells contribute to hyperplastic lesions of podocytopathies and crescentic glomerulonephritis. J Am Soc Nephrol (2009) 1.54
In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: implication for permselective dysfunction of chronic nephropathies. Am J Pathol (2005) 1.54
Mechanisms of progression of chronic kidney disease. Pediatr Nephrol (2007) 1.52
Wnt/β-catenin pathway in podocytes integrates cell adhesion, differentiation, and survival. J Biol Chem (2011) 1.51
Activated omentum slows progression of CKD. J Am Soc Nephrol (2014) 1.50
Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. J Clin Invest (2014) 1.46
Podocyte biology and pathogenesis of kidney disease. Annu Rev Med (2012) 1.32
Cyclin I activates Cdk5 and regulates expression of Bcl-2 and Bcl-XL in postmitotic mouse cells. J Clin Invest (2009) 1.28
Toward the identification of a "renopoietic system"? Stem Cells (2009) 1.27
The role of the podocyte in albumin filtration. Nat Rev Nephrol (2013) 1.26
Dynamic (re)organization of the podocyte actin cytoskeleton in the nephrotic syndrome. Pediatr Nephrol (2003) 1.25
Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease. Kidney Int (2010) 1.25
Inhibition of p66ShcA longevity gene rescues podocytes from HIV-1-induced oxidative stress and apoptosis. J Biol Chem (2009) 1.24
Kruppel-like factor 15 (KLF15) is a key regulator of podocyte differentiation. J Biol Chem (2012) 1.21
Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases. J Am Soc Nephrol (2013) 1.20
Transforming growth factor-beta1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosis. Am J Pathol (2002) 1.19
DNA damage is a novel response to sublytic complement C5b-9-induced injury in podocytes. J Clin Invest (2003) 1.18
Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications. J Transl Med (2011) 1.18
A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue. Am J Pathol (2010) 1.18
Immunopathogenesis of IgAN. Semin Immunopathol (2007) 1.16
Estimating podocyte number and density using a single histologic section. J Am Soc Nephrol (2013) 1.14
Serum suPAR in patients with FSGS: trash or treasure? Pediatr Nephrol (2013) 1.13
Parietal epithelial cell activation marker in early recurrence of FSGS in the transplant. Clin J Am Soc Nephrol (2012) 1.13
Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids. J Am Soc Nephrol (2013) 1.12
Activation of adenosine 2A receptors preserves structure and function of podocytes. J Am Soc Nephrol (2007) 1.12
ANG II promotes autophagy in podocytes. Am J Physiol Cell Physiol (2010) 1.11
Valproic acid attenuates proteinuria and kidney injury. J Am Soc Nephrol (2011) 1.08
Diabetic kidney disease in FVB/NJ Akita mice: temporal pattern of kidney injury and urinary nephrin excretion. PLoS One (2012) 1.06
Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis. Am J Pathol (2009) 1.05
Minimal change nephropathy and focal segmental glomerulosclerosis. Semin Immunopathol (2007) 1.05
The regenerative potential of parietal epithelial cells in adult mice. J Am Soc Nephrol (2014) 1.02
Podocytes and glomerular function with aging. Semin Nephrol (2009) 1.02
HIVAN phenotype: consequence of epithelial mesenchymal transdifferentiation. Am J Physiol Renal Physiol (2009) 1.01
Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy. Clin J Am Soc Nephrol (2012) 1.01
Up-regulation of connexin43 in glomerular podocytes in response to injury. Am J Pathol (2002) 1.01
Estimation of glomerular podocyte number: a selection of valid methods. J Am Soc Nephrol (2013) 1.00
Molecular and cellular events mediating glomerular podocyte dysfunction and depletion in diabetes mellitus. Front Endocrinol (Lausanne) (2014) 0.98
Protective effects of the mTOR inhibitor everolimus on cytoskeletal injury in human podocytes are mediated by RhoA signaling. PLoS One (2013) 0.98
HDAC inhibitors in experimental liver and kidney fibrosis. Fibrogenesis Tissue Repair (2013) 0.96
Role of renal perfusion pressure versus angiotensin II on renal oxidative stress in angiotensin II-induced hypertensive rats. Hypertension (2010) 0.95
Aldosterone induces apoptosis in rat podocytes: role of PI3-K/Akt and p38MAPK signaling pathways. Nephron Exp Nephrol (2009) 0.95
Common histological patterns in glomerular epithelial cells in secondary focal segmental glomerulosclerosis. Kidney Int (2015) 0.94
DC-specific ICAM-3-grabbing nonintegrin mediates internalization of HIV-1 into human podocytes. Am J Physiol Renal Physiol (2010) 0.94
Causes and pathogenesis of focal segmental glomerulosclerosis. Nat Rev Nephrol (2014) 0.94
HIV compromises integrity of the podocyte actin cytoskeleton through downregulation of the vitamin D receptor. Am J Physiol Renal Physiol (2013) 0.93
Antiproteinuric effects of enalapril and losartan: a pilot study. Pediatr Nephrol (2003) 0.92
Aging in the glomerulus. J Gerontol A Biol Sci Med Sci (2012) 0.92
Downregulation of the antioxidant protein peroxiredoxin 2 contributes to angiotensin II-mediated podocyte apoptosis. Kidney Int (2011) 0.92
Podocyte injury-driven intracapillary plasminogen activator inhibitor type 1 accelerates podocyte loss via uPAR-mediated β1-integrin endocytosis. Am J Physiol Renal Physiol (2015) 0.92
A novel mouse model of podocyte depletion. Nephron Exp Nephrol (2012) 0.91
Roflumilast enhances the renal protective effects of retinoids in an HIV-1 transgenic mouse model of rapidly progressive renal failure. Kidney Int (2012) 0.91
Kidney biopsy findings in heterozygous Fabry disease females with early nephropathy. Virchows Arch (2008) 0.91
Estrogen receptor alpha expression in podocytes mediates protection against apoptosis in-vitro and in-vivo. PLoS One (2011) 0.91
Rosuvastatin protects against podocyte apoptosis in vitro. Nephrol Dial Transplant (2008) 0.91
Glomerular diseases: podocyte hypertrophy mismatch and glomerular disease. Nat Rev Nephrol (2012) 0.90
Retinoids as a potential treatment for experimental puromycin-induced nephrosis. Br J Pharmacol (2003) 0.90
Angiotensin II contributes to diabetic renal dysfunction in rodents and humans via Notch1/Snail pathway. Am J Pathol (2013) 0.90
Ubiquitin C-terminal hydrolase-l1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathy. Am J Pathol (2011) 0.89
Progression of chronic renal failure in focal segmental glomerulosclerosis: consequence of podocyte damage or of tubulointerstitial fibrosis? Pediatr Nephrol (2003) 0.87
1, 25-dihydroxyvitamin D3 decreases adriamycin-induced podocyte apoptosis and loss. Int J Med Sci (2010) 0.87
MicroRNA-30 family members regulate calcium/calcineurin signaling in podocytes. J Clin Invest (2015) 0.86
A case of minimal change nephrotic syndrome with immunoglobulin A nephropathy transitioned to focal segmental glomerulosclerosis. Clin Exp Nephrol (2012) 0.85
Role of endoplasmic reticulum stress in apoptosis of differentiated mouse podocytes induced by high glucose. Int J Mol Med (2014) 0.85
Rapamycin-induced modulation of HIV gene transcription attenuates progression of HIVAN. Exp Mol Pathol (2012) 0.85
Losartan chemistry and its effects via AT1 mechanisms in the kidney. Curr Med Chem (2009) 0.85
Podometrics as a Potential Clinical Tool for Glomerular Disease Management. Semin Nephrol (2015) 0.83
Pathogenetic role of glomerular CXCL13 expression in lupus nephritis. Clin Exp Immunol (2014) 0.83
MOF maintains transcriptional programs regulating cellular stress response. Oncogene (2015) 0.82
Discovery of new glomerular disease-relevant genes by translational profiling of podocytes in vivo. Kidney Int (2014) 0.82
A novel source of cultured podocytes. PLoS One (2013) 0.82
Proteomic analysis identifies insulin-like growth factor-binding protein-related protein-1 as a podocyte product. Am J Physiol Renal Physiol (2010) 0.82
Augmenting podocyte injury promotes advanced diabetic kidney disease in Akita mice. Biochem Biophys Res Commun (2014) 0.81
Non-immunologic actions of calcineurin inhibitors in proteinuric kidney diseases. Front Endocrinol (Lausanne) (2014) 0.81
Dynamic changes of urinary proteins in a focal segmental glomerulosclerosis rat model. Proteome Sci (2014) 0.80
Enzymatic disease of the podocyte. Pediatr Nephrol (2010) 0.80
What has the immune system got against the glomerular podocyte? Clin Exp Immunol (2003) 0.80
Counting glomeruli and podocytes: rationale and methodologies. Curr Opin Nephrol Hypertens (2015) 0.80
Endoglin regulates mural cell adhesion in the circulatory system. Cell Mol Life Sci (2015) 0.79
Can kidney regeneration be visualized? Nephron Exp Nephrol (2014) 0.79
How are podocytes affected in nail-patella syndrome? Pediatr Nephrol (2008) 0.79
Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis. Virchows Arch (2015) 0.78
Glomerular homeostasis requires a match between podocyte mass and metabolic load. J Am Soc Nephrol (2012) 0.78
[Chronic recurrent subileus due to Strongyloides stercoralis infection under immunosuppressive therapy]. Dtsch Med Wochenschr (1996) 2.04
Combined report on regular dialysis and transplantation in Europe, XIII, 1982. Proc Eur Dial Transplant Assoc (1983) 1.97
Complement analysis in children with idiopathic membranoproliferative glomerulonephritis: a long-term follow-up. Pediatr Allergy Immunol (2001) 1.80
Plasma creatinine determination in mice and rats: an enzymatic method compares favorably with a high-performance liquid chromatography assay. Kidney Int (2006) 1.79
Donor kidneys of infants and very young children are unacceptable for transplantation. Lancet (1989) 1.76
Microarray analysis of newly synthesized RNA in cells and animals. Proc Natl Acad Sci U S A (2007) 1.44
The role of the podocyte in glomerulosclerosis. Curr Opin Nephrol Hypertens (1999) 1.42
Identification of a new gene locus for adolescent nephronophthisis, on chromosome 3q22 in a large Venezuelan pedigree. Am J Hum Genet (2000) 1.41
Wnt pathway regulation in chronic renal allograft damage. Am J Transplant (2009) 1.39
The polycystic kidney disease protein PKD2 interacts with Hax-1, a protein associated with the actin cytoskeleton. Proc Natl Acad Sci U S A (2000) 1.36
Gene expression profiling of CD34+ cells identifies a molecular signature of chronic myeloid leukemia blast crisis. Leukemia (2006) 1.27
The role of podocytes in the development of glomerular sclerosis. Kidney Int Suppl (1994) 1.26
Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model. Br J Cancer (2007) 1.23
Gene expression signature of primary imatinib-resistant chronic myeloid leukemia patients. Leukemia (2006) 1.22
Characterization of the Han:SPRD rat model for hereditary polycystic kidney disease. Kidney Int (1994) 1.20
Cycles and separations: the histotopography of the urinary concentrating process. Kidney Int (1987) 1.17
From segmental glomerulosclerosis to total nephron degeneration and interstitial fibrosis: a histopathological study in rat models and human glomerulopathies. Nephrol Dial Transplant (1998) 1.14
Reduced capillary density in the myocardium of uremic rats--a stereological study. Kidney Int (1992) 1.12
Structure-stabilizing forces in the glomerular tuft. J Am Soc Nephrol (1995) 1.11
Creatinine clearance, Cockcroft-Gault formula and cystatin C: estimators of true glomerular filtration rate in the elderly? Gerontology (2002) 1.10
Increased epithelial cell proliferation and abnormal extracellular matrix in rat polycystic kidney disease. J Am Soc Nephrol (1998) 1.09
The Forkhead factor FoxQ1 influences epithelial differentiation. J Cell Physiol (2011) 1.08
Tracer studies in the rat demonstrate misdirected filtration and peritubular filtrate spreading in nephrons with segmental glomerulosclerosis. J Am Soc Nephrol (2001) 1.06
Direct determination of vasa recta blood flow in the rat renal papilla. Circ Res (1983) 1.06
Molecular genetic identification of families with juvenile nephronophthisis type 1: rate of progression to renal failure. APN Study Group. Arbeitsgemeinschaft für Pädiatrische Nephrologie. Kidney Int (1997) 1.02
Absent in Melanoma 2 (AIM2) is an important mediator of interferon-dependent and -independent HLA-DRA and HLA-DRB gene expression in colorectal cancers. Oncogene (2011) 0.99
Functional characterisation of decoy receptor 3 in Crohn's disease. Gut (2008) 0.98
A possible role for metalloproteinases in renal cyst development. Am J Physiol Renal Physiol (2001) 0.97
Podocyte injury underlies the progression of focal segmental glomerulosclerosis in the fa/fa Zucker rat. Kidney Int (2001) 0.97
Natural course of the development of histological lesions after 5/6 nephrectomy. Contrib Nephrol (1988) 0.95
A frequent pathway to glomerulosclerosis: deterioration of tuft architecture-podocyte damage-segmental sclerosis. Kidney Blood Press Res (1996) 0.95
Mechanisms of progressive glomerular injury in membranous nephropathy. J Am Soc Nephrol (1998) 0.94
Beneficial effects of CCR1 blockade on the progression of chronic renal allograft damage. Am J Transplant (2007) 0.94
Location of the first genetic locus, PKDr1, controlling autosomal dominant polycystic kidney disease in Han:SPRD cy/+ rat. Hum Mol Genet (1997) 0.94
Biocompatibility of an electrochemical sensor for continuous glucose monitoring in subcutaneous tissue. Diabetes Technol Ther (2005) 0.91
Survival time in cystinosis. A collaborative study. Proc Eur Dial Transplant Assoc (1983) 0.90
Focal overexpression of collagen IV characterizes the initiation of epithelial changes in polycystic kidney disease. Exp Nephrol (1994) 0.90
Outcome of idiopathic membranoproliferative glomerulonephritis in children. Arbeitsgemeinschaft Pädiatrische Nephrologie. Acta Paediatr (1996) 0.90
Molecular characterisation of non-absorptive and absorptive enterocytes in human small intestine. Gut (2006) 0.88
Striking increase of natriuresis by low-dose spironolactone in congestive heart failure only in combination with ACE inhibition: mechanistic evidence to support RALES. Circulation (2000) 0.87
Murine models of polycystic kidney disease. Nephrol Dial Transplant (1996) 0.87
Azotemia and extrarenal manifestations in old female Han:SPRD (cy/+) rats. Kidney Int (1997) 0.86
The swelling-activated chloride channel ClC-2, the chloride channel ClC-3, and ClC-5, a chloride channel mutated in kidney stone disease, are expressed in distinct subpopulations of renal epithelial cells. J Clin Invest (1998) 0.86
Specific regulation of StAR expression in the rat adrenal zona glomerulosa. An in situ hybridization study. J Histochem Cytochem (1998) 0.86
An endocytosis defect as a possible cause of proteinuria in polycystic kidney disease. Am J Physiol Renal Physiol (2001) 0.86
Progression of chronic renal failure in a historical group of patients with nephropathic cystinosis. European Collaborative Study on Cystinosis. Pediatr Nephrol (1994) 0.85
Modulation of Wnt and Hedgehog signaling pathways is linked to retinoic acid-induced amelioration of chronic allograft dysfunction. Am J Transplant (2011) 0.85
Kid-1 expression is high in differentiated renal proximal tubule cells and suppressed in cyst epithelia. Am J Physiol (1998) 0.85
Kidney transplantation in children and adolescents: an analysis of United Network for Organ Sharing Database. Transplant Proc (2009) 0.85
How does podocyte damage result in tubular damage? Kidney Blood Press Res (1999) 0.85
The rat pkd2 protein assumes distinct subcellular distributions in different organs. Am J Physiol (1999) 0.85
Low-protein diet supplemented by keto acids in chronic renal failure: a prospective controlled study. Kidney Int Suppl (1983) 0.85
A 100% 2-year graft survival can be attained in high-risk 15-kg or smaller infant recipients of kidney allografts. Arch Surg (2000) 0.84
Role of obstruction in autosomal dominant polycystic kidney disease in rats. Kidney Int (1996) 0.84
Molecular basis of autosomal-dominant polycystic kidney disease. Cell Mol Life Sci (2002) 0.84
Tubular gelatinase A (MMP-2) and its tissue inhibitors in polycystic kidney disease in the Han:SPRD rat. Kidney Int (1996) 0.83
Presence of renin within intramitochondrial dense bodies of the rat adrenal cortex. Am J Physiol (1996) 0.83
Determinants of GFR depression in early membranous nephropathy. Am J Physiol Renal Physiol (2003) 0.83
Renal osmotic stress-induced cotransporter: expression in the newborn, adult and post-ischemic rat kidney. Kidney Int (1997) 0.82
Mesangial cell-glomerular basement membrane connections counteract glomerular capillary and mesangium expansion. Am J Nephrol (1990) 0.82
Losartan and angiotensin II inhibit aldosterone production in anephric rats via different actions on the intraadrenal renin-angiotensin system. Endocrinology (1999) 0.82
Renal function in predialysis children with chronic renal failure treated with erythropoietin. Pediatr Nephrol (1997) 0.81
The treatment of cystinosis with cysteamine and phosphocysteamine in the United Kingdom and Eire. Pediatr Nephrol (1995) 0.81
A novel transcriptome subtraction method for the detection of differentially expressed genes in highly complex eukaryotes. Nucleic Acids Res (2005) 0.81
Efficacy and immunogenicity of novel erythropoietic agents and conventional rhEPO in rats with renal insufficiency. Kidney Int (2006) 0.81
Chronic lead exposure in rats: effects on blood pressure. Eur J Clin Invest (1993) 0.81
Animal models to induce renal failure: a historical survey. Contrib Nephrol (1988) 0.80
In vivo and in vitro investigations of heterozygous nebulin knock-out mice disclose a mild skeletal muscle phenotype. Neuromuscul Disord (2013) 0.80
Crosstalk in the retinal neurovascular unit - lessons for the diabetic retina. Exp Clin Endocrinol Diabetes (2012) 0.80
Distribution of endothelin receptor subtypes in the rat kidney. Renal and haemodynamic effects of the mixed (A/B) endothelin receptor antagonist bosentan. Eur J Clin Chem Clin Biochem (1995) 0.80
Progression to end-stage renal disease in children with posterior urethral valves. Pediatr Nephrol (1998) 0.80
PAF-receptor in inflammatory versus non inflammatory human epidermis, cell cultures and embryonal cells. Inflamm Res (2003) 0.79
Combined report on regular dialysis and transplantation of children in Europe XII, 1982. Proc Eur Dial Transplant Assoc (1983) 0.79
Biochemical validation of a rat model for polycystic kidney disease: comparison of guanidino compound profile with the human condition. Kidney Int (2006) 0.79
Function and expression of endothelin receptor subtypes in the kidneys of spontaneously hypertensive rats. Cardiovasc Res (1996) 0.79
Alterations of cathepsins B, H and L in proximal tubules from polycystic kidneys of the Han:SPRD rat. Kidney Int (1996) 0.79
Differentiation and cell polarity during renal cyst formation in the Han:SPRD (cy/+) rat, a model for ADPKD. Am J Physiol (1997) 0.79
The development of hypertension in the remnant kidney model after either pole resection or partial infarction of the kidney. J Am Soc Nephrol (1995) 0.79
Glomerular hypertrophy after subtotal nephrectomy: relationship to early glomerular injury. Virchows Arch (1995) 0.79
In vitro formation of cysts derived from a rat model of autosomal dominant polycystic kidney disease. Nephrol Dial Transplant (1996) 0.78
Growth hormone treatment in children with preterminal chronic renal failure: no adverse effect on glomerular filtration rate. Eur J Pediatr (1992) 0.78
Thomas Addis: July 17, 1881-June 4, 1949. Biogr Mem Natl Acad Sci (1994) 0.78
An ever-expanding story of cyst formation. Cell Tissue Res (2000) 0.78
Enteric neurons from postnatal Fgf2 knockout mice differ in neurite outgrowth responses. Auton Neurosci (2012) 0.78
Prostaglandin synthesis inhibitors and vasa recta erythrocyte velocities in the rat. Am J Physiol (1984) 0.78
Changing pattern of chronic renal failure and renal replacement therapy in children and adolescents: a 20-year single centre study. Eur J Pediatr (1993) 0.77
Temporal and regional morphological differences as a consequence of FGF-2 deficiency are mirrored in the myenteric proteome. Pediatr Surg Int (2008) 0.77
A new, unique and simple method for ureteral implantation in kidney recipients with small, defunctionalized bladders. Transplantation (1999) 0.77
Organic anion secretion in polycystic kidney disease. J Am Soc Nephrol (1997) 0.77
Delayed progression of chronic renal failure: a prospective controlled trial with a low protein diet supplemented by keto acids. Contrib Nephrol (1985) 0.77
Chronic hyperglycemia inhibits vasoregression in a transgenic model of retinal degeneration. Acta Diabetol (2013) 0.77
The shape of renal vasa recta capillaries and its effect on calculation of single capillary blood flow. Microvasc Res (1986) 0.77
Acute effects of bezafibrate on blood pressure and renal haemodynamics in SHR and WKY rats. Nephrol Dial Transplant (1998) 0.77
The endothelin antagonist bosentan does not improve survival in severe experimental pancreatitis in rats. Int J Pancreatol (1999) 0.77
Influence of the underlying renal disease on the rate of progression. Contrib Nephrol (1986) 0.77
A new in vitro bioassay for cyst formation by renal cells from an autosomal dominant rat model of polycystic kidney disease. In Vitro Cell Dev Biol Anim (2000) 0.77
Changes of AT(2) receptor levels in the rat adrenal cortex and medulla induced by bilateral nephrectomy and its modulation by circulating ANG II. J Histochem Cytochem (2001) 0.77
Determination of renal tissue ibandronate levels in rats with normal and mildly impaired renal function. J Pharmacol Toxicol Methods (2012) 0.76